Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ana Milena Millan"'
Autor:
Ivan Castellví, Diego Castillo, Hèctor Corominas, Anaís Mariscal, Sandra Orozco, Natividad Benito, Virginia Pomar, Andrés Baucells, Isabel Mur, David de la Rosa-Carrillo, David Lobo, Ana Milena Millan, Nerea Hernández de Sosa, David Filella, Laia Matas, Laura Martínez-Martínez, Cándido Juarez, Jordi Casademont, Pere Domingo
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Coronavirus disease 2019 (COVID-19) has rapidly expanded worldwide. Currently, there are no biomarkers to predict respiratory worsening in patients with mild to moderate COVID-19 pneumonia. Small studies explored the use of Krebs von de Lungen-6 circ
Externí odkaz:
https://doaj.org/article/c7d43db410004423b9c0ce430cda69db
Autor:
Carlos Sanchez-Piedra, M. Victoria Hernández Miguel, Javier Manero, Rosa Roselló, Jesús Tomás Sánchez-Costa, Carlos Rodríguez-Lozano, Cristina Campos, Eduardo Cuende, Jesús Carlos Fernández-Lopez, Sagrario Bustabad, Raquel Martín Domenech, Eva Pérez-Pampín, Javier del Pino-Montes, Ana Milena Millan-Arciniegas, Federico Díaz-González, Juan Jesús Gómez-Reino
Publikováno v:
Reumatología Clínica (English Edition). 15:229-236
Autor:
Eduardo Cuende, M. Victoria Hernández Miguel, Raquel Martín Domenech, Rosa Roselló, Jesús T. Sánchez-Costa, Carlos Sánchez-Piedra, Javier del Pino-Montes, Jesús Carlos Fernández-Lopez, Carlos Rodríguez-Lozano, Ana Milena Millan-Arciniegas, Javier Manero, Eva Perez-Pampin, en representación del Grupo de trabajo Biobadaser Fase, Juan J. Gomez-Reino, Sagrario Bustabad, Federico Díaz-González, Cristina Campos
Publikováno v:
Reumatología Clínica. 15:229-236
Objective Describe the objectives, methods and results of the first year of the new version of the Spanish registry of adverse events involving biological therapies and synthetic drugs with an identifiable target in rheumatic diseases (BIOBADASER III
Autor:
Alicia Alonso-Jimenez, Eduard Gallardo, Ana Milena-Millan, Hèctor Corominas, Ana Carrasco-Rozas, Laura Martínez-Martínez, Ricardo Rojas-García, Carlos Zamora, Xavier Suárez-Calvet, Diego Castillo, Isabel Illa, Ivan Castellví, Elena Cortés-Vicente, Luis Querol, Jorge Alonso-Pérez, Noemi de Luna, Jordi Díaz-Manera, Joana Turón, Esther Fernández-Simón
Publikováno v:
Neurology-Neuroimmunology & Neuroinflammation
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Neurology® Neuroimmunology & Neuroinflammation
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Neurology® Neuroimmunology & Neuroinflammation
ObjectiveTo describe the clinical, serologic and histologic features of a cohort of patients with brachio-cervical inflammatory myopathy (BCIM) associated with systemic sclerosis (SSc) and unravel disease-specific pathophysiologic mechanisms occurrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e335ecfea5fb7da4b2b627e11f72669
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1878
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1878
Autor:
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hector Corominas
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-10 (2023)
Abstract Background Sarilumab, an IL-6 receptor antagonist, is a first-line biologic disease-modifying anti-rheumatic drug for rheumatoid arthritis. The identification of genetic biomarkers as predictors of response to sarilumab could allow for a per
Externí odkaz:
https://doaj.org/article/0444fe7ddf56436ab6f8401650ec4da3
Autor:
Santos Castañeda, Ricardo Blanco, Héctor Corominas, Patricia Carreira, Ivan Castellví, Eugenio De Miguel, Javier Narváez, Judit LLuch, Ivette Casafont-Solé, Jose María Pego, Lydia Abasolo, Carmen Larena, Francisco Ortiz-Sanjuán, Clara Moriano Morales, Elvira Díez Álvarez, Miguel Ángel González-Gay, Berta Magallares, Monica Ibañez Barcelo, Laura Garrido Courel, Vanesa Hernandez Hernandez, Patricia Moya Alvarado, Anne Riveros Frutos, Margarida Vasques Rocha, María Alcalde Villar, Antonio Juan Mas, Julio Sanchez, Joan Calvet, Clara Molina Almela, Amalia Rueda Cid, Cristina Campos Fernández, Carmen Riesco Bárcena, Patricia Moran Alvarez, Judit Font Urgelles, Alejandro Muñoz Jiménez, Delia Fernández-Lozano, Iñigo Hernández-Rodríguez, Marta Domínguez-Álvaro, Maite Silva-Díaz, Joaquín María Belzunegui, Eva Galíndez-Agirregoikoa, Vicente Aldaroso, Javier Loricera, Noemi Garrido-Puñal, Vanessa Andrea Navarro, Tarek Carlos Salman Monte, Trinidad Pérez Sandoval, Ismael González Fernández, Javier Mendizábal-Mateos, María Concepción Fito Manteca, Natividad del Val del Amo, Loreto Horcada Rubio, Inmaculada Paniagua Zudaire, Ricardo Gutiérrez Polo, Juliana Restrepo Vélez, Eduardo Loza Cortina, Elisa Fernández Fernández, Tomás Almorza, Leticia Léon Mateos, Luis Rodríguez Rodríguez, Pia Mercedes Lois Bermejo, Selene Labrada Arrabal, Susana Holgado Pérez, Jordi Camins, Javier Calvo Catalá, Rafael Benito Melero, Francisco Maceiras, Nair Pérez, Ceferino Barbazán, Irena Altabás, John Guzman, Paula Valentina Estrada Alarcón, Ana Milena Millán, AnaF Cruz Valenciano, Félix Cabero del Pozo, AnaBelén Rodríguez Cambrón, Cristina Macia Villa, Inmaculada Ros Vilamajó, Elide Toniolo, Ana Paula Cacheda, María Sagrario Bustabad Reyes, María García González, Alicia García Dorta, Jaime Calvo Allen, Miren Uriarte-Ecenarro, Cristina Valero Martínez, Esther F Vicente Rabaneda, Carlos García Porrúa, Carlota Laura Iñiguez Ubiaga, Noelia Álvarez Rivas, Tomás Ramón Vázquez Rodríguez, José Alberto Miranda Filloy, Amalia Sánchez-Andrade Fernández, Carlos Galisteo Lencastre Da Veiga, María Jesús García Villanueva, Marina Tortosa Cabañas, Marta Serrano Warleta, Aliuska Palomeque Vargas, Alberto Ruiz Román, Clara Aguilera Cros, JoséA Román Ivorra, Anderson Huaylla, Itziar Calvo Zorrilla, Jesús A Valero-Jaimes, Luis López Domínguez, Cesar Antonio Egues Dubuc, Lucia Silva Fernández
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objective This study aimed to estimate the incidence of giant cell arteritis (GCA) in Spain and to analyse its clinical manifestations, and distribution by age group, sex, geographical area and season.Methods We included all patients diagnosed with G
Externí odkaz:
https://doaj.org/article/e9f8b06cb9dc42eb8922f2097ea3286a
Autor:
Carlos, Sanchez-Piedra, M Victoria, Hernández Miguel, Javier, Manero, Rosa, Roselló, Jesús Tomás, Sánchez-Costa, Carlos, Rodríguez-Lozano, Cristina, Campos, Eduardo, Cuende, Jesús Carlos, Fernández-Lopez, Sagrario, Bustabad, Raquel, Martín Domenech, Eva, Pérez-Pampín, Javier, Del Pino-Montes, Ana Milena, Millan-Arciniegas, Federico, Díaz-González, Juan Jesús, Gómez-Reino
Publikováno v:
Reumatologia clinica. 15(4)
Describe the objectives, methods and results of the first year of the new version of the Spanish registry of adverse events involving biological therapies and synthetic drugs with an identifiable target in rheumatic diseases (BIOBADASER III).Multicen
Autor:
José A. Gómez-Puerta, David Lobo-Prat, Carolina Perez-García, Andrés Ponce, Beatriz Frade-sosa, Ana Milena Millán Arciniegas, Fabiola Ojeda, Virginia Ruiz-Esquide, Hector Corominas
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ObjectivesTo describe different clinical patterns of rheumatic immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICI) and their rheumatic and oncologic outcomes.MethodsWe classified clinical syndromes according to five di
Externí odkaz:
https://doaj.org/article/f8de84ff33164c8e8b83667335f75ddd
Autor:
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Héctor Corominas
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1942 (2022)
Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by chronic arthritis that may lead to irreversible joint damage and significant disability. Patients with RA are commonly treated with Tocilizumab (TCZ), an IL-6 receptor (IL-6
Externí odkaz:
https://doaj.org/article/c77ef964cf5745659f5d71f8609ecbda
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.